Developing first-in-class therapeutics to cure incurable cancers
Location: United States, New Jersey, Princeton
Employees: 1-10
Total raised: $13.2M
Founded date: 2019
Investors 4
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
| 19.05.2021 | MassChalle... | masschalle... |
| 19.07.2023 | WRF Capita... | wrfseattle... |
| - | Endless Fr... | endlessfro... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.07.2023 | Series A | $5.2M | Accelerato... |
| 18.03.2022 | Series A | $8M | - |
Mentions in press and media 6
| Date | Title | Description |
| 20.07.2023 | KayoThera Completes $5.2M Series A Extension | SEATTLE, WA, KayoThera, a therapeutics company developing oral, small molecule inhibitors of the retinoid pathway, announced a $5.2 million Series A Extension funding round. >> Click here for more funding data on KayoThera >>... |
| 18.03.2022 | KayoThera Raises $8M in Series A Financing | KayoThera, a Seattle, WA-based early-stage therapeutics company advancing novel cancer immunotherapies, raised $8M in Series A funding. The round was led by Accelerator Life Science Partners (“ALSP”) with participation from BioAdvance and 7... |
| 16.03.2022 | KayoThera Raises $8M in Series A | PRINCETON, NJ, KayoThera, an early-stage therapeutics company, has closed an $8 million Series A round of financing led by Accelerator Life Science Partners. >> Click here for more funding data on KayoThera >> To export Kayo... |
| 17.05.2021 | MassChallenge Switzerland Announces 6th Cohort | May 17, 2021 (Renens, Switzerland) - MassChallenge Switzerland, part of MassChallenge’s global network of innovators, today announced the 97 early-stage startups invited to join the 2021 Accelerator Program. These selected startups have be... |
| - | KayoThera | “Kayothera | Curing incurable cancers” |
| - | KayoThera: Early-Stage Therapeutics Company Secures $5.2 Million In Grant And Expanded Series A Funding | KayoThera – an early-stage therapeutics company developing first-in-class, oral, small molecule inhibitors of the retinoid pathway – recently announced the strengthening of its financial resources through multiple grant awards and expansion... |